Nemaura Medical Inc. (NMRD)
OTCMKTS
· Delayed Price · Currency is USD
0.0040
-0.0016 (-28.57%)
Oct 17, 2024, 4:00 PM EDT
Nemaura Medical Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2018 - 2014 |
| Revenue | - | 0.08 | 0.5 | - | - | - | Upgrade
|
| Revenue Growth (YoY) | - | -84.71% | - | - | - | - | Upgrade
|
| Cost of Revenue | 1.48 | 1.55 | 0.34 | - | - | - | Upgrade
|
| Gross Profit | -1.48 | -1.48 | 0.16 | - | - | - | Upgrade
|
| Selling, General & Admin | 8.41 | 5.6 | 6.17 | 3.03 | 2.77 | 2.18 | Upgrade
|
| Research & Development | 1.89 | 1.54 | 1.56 | 1.55 | 2.01 | 2.3 | Upgrade
|
| Operating Expenses | 10.3 | 7.14 | 7.73 | 4.59 | 4.78 | 4.48 | Upgrade
|
| Operating Income | -11.78 | -8.62 | -7.57 | -4.59 | -4.78 | -4.48 | Upgrade
|
| Interest Expense | -5.67 | -6.41 | -6.67 | -2.01 | - | - | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 4.46 | 1.86 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -9.67 | -13.16 | -14.24 | -6.59 | -4.77 | -4.45 | Upgrade
|
| Asset Writedown | -0.98 | -0.98 | - | - | - | - | Upgrade
|
| Pretax Income | -10.65 | -14.14 | -14.24 | -6.59 | -4.77 | -4.45 | Upgrade
|
| Income Tax Expense | - | - | -0.35 | -0.34 | -0.61 | - | Upgrade
|
| Net Income | -10.65 | -14.14 | -13.89 | -6.26 | -4.16 | -4.45 | Upgrade
|
| Net Income to Common | -10.65 | -14.14 | -13.89 | -6.26 | -4.16 | -4.45 | Upgrade
|
| Shares Outstanding (Basic) | 28 | 25 | 23 | 22 | 21 | 18 | Upgrade
|
| Shares Outstanding (Diluted) | 28 | 25 | 23 | 22 | 21 | 18 | Upgrade
|
| Shares Change (YoY) | 18.51% | 6.39% | 4.94% | 7.10% | 15.01% | 20.55% | Upgrade
|
| EPS (Basic) | -0.37 | -0.57 | -0.59 | -0.28 | -0.20 | -0.25 | Upgrade
|
| EPS (Diluted) | -0.38 | -0.57 | -0.59 | -0.28 | -0.20 | -0.25 | Upgrade
|
| Free Cash Flow | -9.74 | -8.83 | -6.99 | -6.09 | -3.61 | -3.62 | Upgrade
|
| Free Cash Flow Per Share | -0.34 | -0.35 | -0.30 | -0.27 | -0.17 | -0.20 | Upgrade
|
| Gross Margin | - | - | 31.67% | - | - | - | Upgrade
|
| Operating Margin | - | -11182.18% | -1502.35% | - | - | - | Upgrade
|
| Profit Margin | - | -18358.00% | -2755.83% | - | - | - | Upgrade
|
| Free Cash Flow Margin | - | -11458.32% | -1386.32% | - | - | - | Upgrade
|
| EBITDA | -11.29 | -8.17 | -7.34 | -4.49 | -4.72 | -4.44 | Upgrade
|
| D&A For EBITDA | 0.49 | 0.44 | 0.23 | 0.1 | 0.05 | 0.03 | Upgrade
|
| EBIT | -11.78 | -8.62 | -7.57 | -4.59 | -4.78 | -4.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.